Copper-cysteamine Nanoparticle-mediated Microwave Dynamic Therapy Improves Cancer Treatment with Induction of Ferroptosis

Overview

Journal Bioact Mater

Specialty Biomedical Engineering

Date 2023 Jan 12

PMID 36632507

Authors

Hui Zhou

Zhongtao Liu

Zijian Zhang

Nil Kanatha Pandey

Eric Amador

William Nguyen

Lalit Chudal

Li Xiong

Wei Chen

Yu Wen

Affiliations

Soon will be listed here.

Abstract

Photodynamic Therapy (PDT) holds a great promise for cancer patients, however, due to the hypoxic characteristics of most solid tumors and the limited penetration depth of light in tissues, the extensive clinical application of PDT is limited. Herein, we report microwave induced copper-cysteamine (Cu-Cy) nanoparticles-based PDT as a promising cancer treatment to overcome cancer resistance in combination with ferroptosis. The treatment efficiency of Cu-Cy-mediated microwave dynamic therapy (MWDT) tested on HCT15 colorectal cancer (CRC) cells via cell titer-blue cell viability assay and live/dead assay reveal that Cu-Cy upon MW irradiation can effectively destroy HCT15 CRC cells with average IC-50 values of 20 μg/mL. The cytotoxicity of Cu-Cy to tumor cells after MW stimulation can be alleviated by ferroptosis inhibitor. Furthermore, Cu-Cy mediated MWDT could deplete glutathione peroxide 4 (GPX4) and enhance lipid peroxides (LPO) and malondialdehyde (MDA). Our findings demonstrate that MW-activated Cu-Cy killed CRC cells by inducing ferroptosis. The superior antitumor efficacy of the Cu-Cy was corroborated by a HCT15 tumor-bearing mice model. Immunohistochemical experiments showed that the GPX4 expression level in Cu-Cy + MW group was significantly lower than that in other groups. Overall, these findings demonstrate that Cu-Cy nanoparticles have a safe and promising clinical application prospect in MWDT for deep-seated tumors and effectively inhibit tumor cell proliferation by inducing ferroptosis, which provides a potential solution for cancer resistance.

Citing Articles

Ferroptosis in thyroid cancer: mechanisms, current status, and treatment.

Tian W, Su X, Hu C, Chen D, Li P Front Oncol. 2025; 15:1495617.

PMID: 39917169 PMC: 11798778. DOI: 10.3389/fonc.2025.1495617.

Role of copper homeostasis and cuproptosis in heart failure pathogenesis: implications for therapeutic strategies.

Liu Z, Gan Y, Shen Z, Cai S, Wang X, Li Y Front Pharmacol. 2025; 15():1527901.

PMID: 39850564 PMC: 11754225. DOI: 10.3389/fphar.2024.1527901.

Copper homeostasis and cuproptosis in central nervous system diseases.

Zhu Z, Song M, Ren J, Liang L, Mao G, Chen M Cell Death Dis. 2024; 15(11):850.

PMID: 39567497 PMC: 11579297. DOI: 10.1038/s41419-024-07206-3.

Inorganic Nanomedicine-Mediated Ferroptosis: A Synergistic Approach to Combined Cancer Therapies and Immunotherapy.

Mohapatra A, Mohanty A, Park I Cancers (Basel). 2024; 16(18).

PMID: 39335181 PMC: 11430644. DOI: 10.3390/cancers16183210.

Ferroptosis resistance in cancer cells: nanoparticles for combination therapy as a solution.

Adzavon K, Zhao W, He X, Sheng W Front Pharmacol. 2024; 15:1416382.

PMID: 38962305 PMC: 11219589. DOI: 10.3389/fphar.2024.1416382.

References

Gu T, Dong H, Lu T, Han L, Zhan Y . Fluoride ion accelerating degradation of organic pollutants by Cu(II)-catalyzed Fenton-like reaction at wide pH range. J Hazard Mater. 2019; 377:365-370. DOI: 10.1016/j.jhazmat.2019.05.073. View

Kinowaki Y, Taguchi T, Onishi I, Kirimura S, Kitagawa M, Yamamoto K . Overview of Ferroptosis and Synthetic Lethality Strategies. Int J Mol Sci. 2021; 22(17). PMC: 8430824. DOI: 10.3390/ijms22179271. View

Fu J, Li T, Yang Y, Jiang L, Wang W, Fu L . Activatable nanomedicine for overcoming hypoxia-induced resistance to chemotherapy and inhibiting tumor growth by inducing collaborative apoptosis and ferroptosis in solid tumors. Biomaterials. 2020; 268:120537. DOI: 10.1016/j.biomaterials.2020.120537. View

Chu X, Li K, Guo H, Zheng H, Shuda S, Wang X . Exploration of Graphitic-CN Quantum Dots for Microwave-Induced Photodynamic Therapy. ACS Biomater Sci Eng. 2021; 3(8):1836-1844. DOI: 10.1021/acsbiomaterials.7b00110. View

Fu C, Zhou H, Tan L, Huang Z, Wu Q, Ren X . Microwave-Activated Mn-Doped Zirconium Metal-Organic Framework Nanocubes for Highly Effective Combination of Microwave Dynamic and Thermal Therapies Against Cancer. ACS Nano. 2017; 12(3):2201-2210. DOI: 10.1021/acsnano.7b08868. View

Friedmann Angeli J, Krysko D, Conrad M . Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion. Nat Rev Cancer. 2019; 19(7):405-414. DOI: 10.1038/s41568-019-0149-1. View

Li M, Zhang F, Su Y, Zhou J, Wang W . Nanoparticles designed to regulate tumor microenvironment for cancer therapy. Life Sci. 2018; 201:37-44. DOI: 10.1016/j.lfs.2018.03.044. View

Ozkan E, Bakar-Ates F . Ferroptosis: A Trusted Ally in Combating Drug Resistance in Cancer. Curr Med Chem. 2021; 29(1):41-55. DOI: 10.2174/0929867328666210810115812. View

Bhandari V, Hoey C, Liu L, Lalonde E, Ray J, Livingstone J . Molecular landmarks of tumor hypoxia across cancer types. Nat Genet. 2019; 51(2):308-318. DOI: 10.1038/s41588-018-0318-2. View

10.

Zhang G, Xie W, Xu Z, Si Y, Li Q, Qi X . CuO dot-decorated Cu@GdO core-shell hierarchical structure for Cu(i) self-supplying chemodynamic therapy in combination with MRI-guided photothermal synergistic therapy. Mater Horiz. 2021; 8(3):1017-1028. DOI: 10.1039/d0mh01685c. View

11.

Petroni G, Buque A, Coussens L, Galluzzi L . Targeting oncogene and non-oncogene addiction to inflame the tumour microenvironment. Nat Rev Drug Discov. 2022; 21(6):440-462. DOI: 10.1038/s41573-022-00415-5. View

12.

Zhou H, Liu Z, Wang Y, Wen X, Amador E, Yuan L . Colorectal liver metastasis: molecular mechanism and interventional therapy. Signal Transduct Target Ther. 2022; 7(1):70. PMC: 8897452. DOI: 10.1038/s41392-022-00922-2. View

13.

Chen T, Chuang J, Ko C, Kao T, Yang P, Yu C . AR ubiquitination induced by the curcumin analog suppresses growth of temozolomide-resistant glioblastoma through disrupting GPX4-Mediated redox homeostasis. Redox Biol. 2020; 30:101413. PMC: 6940696. DOI: 10.1016/j.redox.2019.101413. View

14.

Wu Q, Xia N, Long D, Tan L, Rao W, Yu J . Dual-Functional Supernanoparticles with Microwave Dynamic Therapy and Microwave Thermal Therapy. Nano Lett. 2019; 19(8):5277-5286. DOI: 10.1021/acs.nanolett.9b01735. View

15.

Zhao Y, Wang S, Ding Y, Zhang Z, Huang T, Zhang Y . Piezotronic Effect-Augmented CuO-BaTiO Sonosensitizers for Multifunctional Cancer Dynamic Therapy. ACS Nano. 2022; 16(6):9304-9316. DOI: 10.1021/acsnano.2c01968. View

16.

Zhen X, Chudal L, Pandey N, Phan J, Ran X, Amador E . A powerful combination of copper-cysteamine nanoparticles with potassium iodide for bacterial destruction. Mater Sci Eng C Mater Biol Appl. 2020; 110:110659. PMC: 7100965. DOI: 10.1016/j.msec.2020.110659. View

17.

Dekker E, Tanis P, Vleugels J, Kasi P, Wallace M . Colorectal cancer. Lancet. 2019; 394(10207):1467-1480. DOI: 10.1016/S0140-6736(19)32319-0. View

18.

Long D, Liu T, Tan L, Shi H, Liang P, Tang S . Multisynergistic Platform for Tumor Therapy by Mild Microwave Irradiation-Activated Chemotherapy and Enhanced Ablation. ACS Nano. 2016; 10(10):9516-9528. DOI: 10.1021/acsnano.6b04749. View

19.

Mou Y, Wang J, Wu J, He D, Zhang C, Duan C . Ferroptosis, a new form of cell death: opportunities and challenges in cancer. J Hematol Oncol. 2019; 12(1):34. PMC: 6441206. DOI: 10.1186/s13045-019-0720-y. View

20.

Chu X, Mao L, Johnson O, Li K, Phan J, Yin Q . Exploration of TiO nanoparticle mediated microdynamic therapy on cancer treatment. Nanomedicine. 2019; 18:272-281. DOI: 10.1016/j.nano.2019.02.016. View